Mr. Jim Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) CLINICAL STUDY UPDATE #2

Ndatalyze Corp. has been advised of further preliminary results of the York University clinical study related to the corporation's YMI mental condition assessment program. The model has been further refined to target overdiagnosis and is currently generating 93% precision (or "positive predictive value") when using psychiatrist/psychologist diagnoses as the "ground truth".

Jim Durward, CEO/CTO states: " Mental condition diagnoses are generated by three disciplines: Psychiatrists (medical doctors who are also highly-trained in "matters of the mind" and who can prescribe psychotropic drugs), Psychologists (persons who are not a medical doctors but are highly-trained in matters of the mind, but who cannot prescribe drugs), or Primary Physicians (family doctors - medical doctors with little mental condition training but who can prescribe psychotropic drugs). Our model uses only Psychiatrist/Psychologist diagnoses as the "ground truth" as these are the disciplines with high degrees of mental condition training."

According to Johns Hopkins Bloomberg School of Public Health, Americans are over-diagnosed and over-treated for depression. One of their studies examined adults with clinician-identified depression and individuals who experienced major depressive episodes within a 12-month period. It found that when assessed for major depressive episodes using a structured interview, only 38.4 percent of adults with clinician-identified depression met the 12-month criteria for depression, despite the majority of participants being prescribed and using psychiatric medications*.

Once complete, the York study is expected to demonstrate the benefit of combining DNA data with environmental biometric data when predicting depression susceptibilities.

About YMI

YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a fuller understanding of how mental health develops, and how to improve mental wellbeing. YMI combines supervised machine-learning with a proprietary Reference Database to predict an individual's predisposition toward a variety of common mental conditions, both current and forward in time.

YMI is poised to revolutionize mental health diagnoses while ensuring a sustainable revenue stream. By strategically addressing the causes of misdiagnosis, establishing credibility through clinical studies, and targeting key markets, YMI aligns both societal impact and financial success.

About Mindbalanced, Inc.

Mindbalanced's vision is to redefine mental healthcare through an integrative, personalized approach leveraging cutting edge technology and non-invasive treatment protocols. By harnessing evidence-based data we aim to predict and enhance mental wellbeing, taking into account individual predispositions and environmental factors thereby fostering

We seek Safe Harbor.